You will be responsible for:
· Define and implement product characterization strategy for in vivo CAR-T including LNP, mRNA and targeted LV modalities from early development to late stages of development.
· Lead the identification and justification of CQAs for CGT products using the Quality by Design (QbD) principles.
· Lead the execution of the advanced methodologies associated with comparability and deep characterization of cell and gene therapy.
· Develop and refine the control strategy linking process parameters to CQAs.
· Apply DOE and statistical modeling to establish structure- function and process-product relationships.
· Author or coordinate appropriate IND/IMPD/BLA/MAA sections & interact with regulatory agencies to address product characterization related inquiries.
· Effectively communicate characterization results and scientific data to cross-functional teams, project teams, and health authority as needed.
· Promote strong partnerships and collaboration with Process Development functional leaders, data sciences, Janssen Supply Chain leaders, Quality Assurance, and Discovery.
· Contribute to technical forums both internal and external to the company to share knowledge and approaches related to deep product characterization strategies as they relate to cell and gene therapy products.
· Identify/collaborate with partners in academia or industry to implement innovative ideas or characterization approaches.
· Stay up to date with industry standards, guidelines, and regulatory requirements related to Advanced therapies, comparability studies and product characterization.
· Author comprehensive reports and presentations to communicate findings and technical data to internal and external stakeholders.
· Contribute to the development and enhancement of standard operating procedures (SOPs) and best practices for product characterization.